1	Aplicar	aplicar	VMN0000	C1632850	calificador	0-7	191(0)_ANS_clinical_caseMIR	SENT1	-	-
2	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	8-19	191(0)_ANS_clinical_caseMIR	SENT1	-	-
3	con	con	SPS00	C0332287	atributo	20-23	191(0)_ANS_clinical_caseMIR	SENT1	-	-
4	un	un		C0205447_1	calificador_1	24-26	191(0)_ANS_clinical_caseMIR	SENT1	-	-
5	inhibidor	inhibidor	NCMS000	-	-	27-36	191(0)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
6	de	de	SPS00	C0332285	atributo	37-39	191(0)_ANS_clinical_caseMIR	SENT1	I-Grp_Medicamento	-
7	la	el	DA0FS0	-	-	40-42	191(0)_ANS_clinical_caseMIR	SENT1	-	-
8	somatostatina	somatostatina	NCFS000	C0037659	sustancia	43-56	191(0)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
9	(	(	Fpa	-	-	57-58	191(0)_ANS_clinical_caseMIR	SENT1	-	-
10	octreótido	octreótido	NC00SC0	C0028833	sustancia	58-68	191(0)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
11	)	)	Fpt	-	-	68-69	191(0)_ANS_clinical_caseMIR	SENT1	-	-
12	.	.	Fp	-	-	70-71	191(0)_ANS_clinical_caseMIR	SENT1	-	-

